Even when vision seems perfect, your eyes can be silently signaling trouble. Many serious eye conditions start without pain ...

FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Dravet ...

100 percent of evaluable patients achieved minimal residual disease (MRD) negativity following induction therapy in updated results from the Phase 2 MajesTEC-5 study "Exploring TECVAYLI, with its ...

One man living with major depressive disorder shares how working with his psychiatrist led him to understand his ...

Early and aggressive treatment of dry eye disease can prevent progression and preserve ocular health, especially in glaucoma patients. A multifaceted approach is necessary for managing meibomian gland ...

Bristol Myers Squibb (NYSE: BMY) today announced the launch of its COBENFY Connections™ initiative in partnership with culinary expert, TV host and author Gail Simmons.* Launching on World Mental ...

100 percent of evaluable patients achieved minimal residual disease (MRD) negativity following induction therapy in updated results from the Phase 2 MajesTEC-5 study TORONTO, Sept. 19, 2025 ...

Red eyes can be caused by mild problems like contact overuse and eye strain — or more serious issues like glaucoma or uveitis ...

Nefopam is a type of non-narcotic painkiller. According to the NHS website, it seems that the drug helps to "block pain ...

Open-angle glaucoma often has no symptoms until vision loss begins, so regular screening is important. You can use eye drops and laser therapy to slow the progression of open-angle glaucoma. Try using ...

Open-angle glaucoma often has no symptoms until vision loss begins, so regular screening is important. You can use eye drops ...

“Glaucoma was associated [with] an increased risk of dementia using a demographically matched control cohort and adjusting for comorbidities. Our results align with previous meta-analyses that ...